SLXN · Silexion Therapeutics Corp
AI read · Bad for SLXN
The AI's read
Silexion filed an 8-K showing a notice of delisting for failure to meet listing standards. That puts the equity at immediate survival risk and makes liquidity evaporate. The market reacted hard — shares slid about 18% to $0.015 today. A selloff this size matters, but formal delisting or trading transfer can trigger another wave down. We lean bearish. Delisting and an OTC transfer typically crush recoverable equity value unless management lands urgent financing or a reverse action quickly.